Email ID
Password
Scrip   
Abbott to suspend marketing of obesity drug sibutramine in EU
22 January 2010
Malini Guha

Abbott will suspend European sales of its anti-obesity drug Reductil (sibutramine) after the CHMP recommended its marketing suspension on the basis of the increased cardiovascular (CV) events seen with it in the SCOUT trial, which included patients at high risk for CV disease. Cardiovascular...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36